Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral presentation of minocycline-induced black bone disease.
Odell EW, Hodgson RP, Haskell R. Odell EW, et al. Among authors: haskell r. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Apr;79(4):459-61. doi: 10.1016/s1079-2104(05)80128-3. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995. PMID: 7614206
An unusual intraosseous melanoma in the maxillary alveolus.
Lombardi T, Haskell R, Morgan PR, Odell EW. Lombardi T, et al. Among authors: haskell r. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Dec;80(6):677-82. doi: 10.1016/s1079-2104(05)80251-3. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995. PMID: 8680975
Bilateral primary seminal vesicle carcinoma.
Ormsby AH, Haskell R, Ruthven SE, Mylne GE. Ormsby AH, et al. Among authors: haskell r. Pathology. 1996 May;28(2):196-200. doi: 10.1080/00313029600169883. Pathology. 1996. PMID: 8743830
Primary amyloidosis of the urinary bladder and ureters.
Ferch R, Haskell R, Farebrother T. Ferch R, et al. Among authors: haskell r. Br J Urol. 1997 Dec;80(6):953-4. doi: 10.1046/j.1464-410x.1997.t01-1-00329.x. Br J Urol. 1997. PMID: 9439418 No abstract available.
Correction to "PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models".
Berlin M, Cantley J, Bookbinder M, Bortolon E, Broccatelli F, Cadelina G, Chan EW, Chen H, Chen X, Cheng Y, Cheung TK, Crew AP, Davenport K, DiNicola D, Dong H, Gordon D, Hamman BD, Harbin A, Haskell R, He M, Hole AJ, Januario T, Kerry PS, Koenig SG, Li L, Merchant M, Pérez-Dorado I, Pizzano J, Quinn C, Rose CM, Rousseau E, Snyder LB, Soto L, Staben LR, Sun H, Tian Q, Wang G, Wang J, Wang W, Ye CS, Ye X, Zhang P, Zhou Y, Yauch R, Dragovich PS. Berlin M, et al. Among authors: haskell r. J Med Chem. 2025 Jun 12;68(11):12284. doi: 10.1021/acs.jmedchem.5c01287. Epub 2025 May 21. J Med Chem. 2025. PMID: 40395158 No abstract available.
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.
Berlin M, Cantley J, Bookbinder M, Bortolon E, Broccatelli F, Cadelina G, Chan EW, Chen H, Chen X, Cheng Y, Cheung TK, Davenport K, DiNicola D, Gordon D, Hamman BD, Harbin A, Haskell R, He M, Hole AJ, Januario T, Kerry PS, Koenig SG, Li L, Merchant M, Pérez-Dorado I, Pizzano J, Quinn C, Rose CM, Rousseau E, Soto L, Staben LR, Sun H, Tian Q, Wang J, Wang W, Ye CS, Ye X, Zhang P, Zhou Y, Yauch R, Dragovich PS. Berlin M, et al. Among authors: haskell r. J Med Chem. 2024 Jan 25;67(2):1262-1313. doi: 10.1021/acs.jmedchem.3c01781. Epub 2024 Jan 5. J Med Chem. 2024. PMID: 38180485
119 results